Ryan Polselli

Ryan Polselli

Breast Imaging Radiologist

Founder and CEO, MammoLink®


About Me

Ryan J. Polselli, M.D. 
435 Manor Blvd                                                                                   
Palm Harbor, FL  34683
Email: ryan.polselli@icloud.com                                                             
p: (912) 667-8654                                                                                       
f: (727) 940-5080

06/2015 - Present 
Board Certified Radiologist
Global Imaging Specialists
Palm Harbor, Florida

Breast imaging and general radiologist for numerous outpatient imaging centers in the Tampa Bay, St. Petersburg, and Sarasota areas of Florida. 

Breast imaging studies and procedures performed include screening and diagnostic mammography, breast tomosynthesis, breast ultrasound, breast MRI, and ultrasound and stereotactic guided core biopsies.

Most light diagnostic imaging modalities and light interventional procedures performed including arthrograms, hysterosalpingograms, sonohysterograms, ultrasound guided core biopsies, fine needle aspirations, myelograms, joint injections, and CT guided biopsies.

Interpret over 20,000 mammograms annually.

ACR lead interpreting mammographer for multiple facilities with 100 percent pass rate for all initial ACR new equipment applications and annual re-accreditation inspections.

Own and maintain physicist certified dual monitor mammography reading workstation for remote mammography interpretation.

01/2013 - Present 
Founder and CEO
Palm Harbor, Florida

Limited liability company in Florida offering in-office mammography services for primary care and OB-gyn physicians.

Markets medical devices designed to improve the breast cancer screening and diagnostic experience. 

Originally started in 2013 with two provisional patents for medical devices that decrease medical errors in the field of breast imaging.

09/2012 - 12/2012 
Director of Breast Imaging
Memorial Health University Medical Center                                 

Medical Director of Memorial Health University Medical Center Breast Imaging Department. 

Awarded Breast Center of Excellence (BCOE) designation from the National Accreditation Program for Breast Centers (NAPBC).                                          
Developed and implemented interventional breast MRI services and protocols including MRI guided breast biopsies. 

Developed methodology and provided expertise to achieve a statistically significant increase in the detection rate of breast cancer in screening patients.

Restructured organizational protocols to result in a 30% increase in efficiency.

Trained and mentored radiology residents 

11/2011 - 09/2012
Breast Imaging
Emory University, Department of Radiology Atlanta, Georgia 

07/2007 - 06/2011
Diagnostic Radiology
Emory University, Department of Radiology Atlanta, Georgia 

07/2006 - 06/2007
Transitional Residency, Internal Medicine Spartanburg Regional Community Hospital Spartanburg, South Carolina 

08/2002 - 05/2006
Doctor of Medicine
University of South Florida College of Medicine 
Tampa, Florida 

Bachelor of Science in Biology, Summa cum laude 
University of South Florida
Tampa, Florida 

1995 - 1998
Bachelor of Science in Physics, Summa cum laude 
Florida Atlantic University
Boca Raton, Florida 

1993 - 1994
Midshipman Candidate
United States Naval Academy Preparatory School                                                                                            Newport, Rhode Island 

1992 - 1993
Petty Officer
United States Naval Nuclear Power School                                    
Orlando, Florida 

2003 - 2005
University of South Florida College of Medicine, Department of Vascular Surgery
Tampa, FL

The Effects of Dichloroacetate in Ischemic Rat Skeletal Muscle 
Dichloroacetate, a key component of cellular respiration, was once thoroughly investigated in the field of cardiology as a potential drug for the treatment of ischemia in cardiac muscle. Disappointingly, the results failed to show any significant clinical benefit for the treatment of patients suffering from myocardial ischemia. 

However, prior to this experiment in 2004, Dichloroacetate had never been investigated for its potential benefits in ischemia skeletal muscle. Given the significant metabolic and respiratory differences between striated muscle and cardiac myocytes, it was a reasonable hypothesis that the drug might still hold some clinical benefit in preventing ischemic injury and or re-perfusion injury in patients suffering from prolonged limb ischemia, such as those facing limb threatening injuries on the battle field where surgical assistance is frequently delayed. 

This randomized control trial examined the levels of cellular ATP and various cytokines in the anterior tibialis muscle of 32 Sprague-Dawley rats randomly assigned to ischemic and control groups. The results of the study showed statistically significant (p < .05) differences in the levels of ATP and IL-2. This initial study encouraged subsequent investigation into the potential clinical usefulness of Dichloracetate. Unfortunately, follow-up studies failed to show enough significant benefit for clinical usefulness. 

This research was presented at the 32nd annual Society of Military Vascular Surgeons Conference, and was awarded Superior Research Presentation by the University of South Florida College of Medicine. 

Licensure and Certifications 
Florida Board of Medicine
Missouri Board of Registration for the Healing Arts
Diplomate of the American Board of Radiology                    

Certified Clinical Densitometrist, International Society of Clinical Densitometry

Alphanumeric Breast Biopsy Marker (US #61/769,632) for the Identification of Procedural Date and Biopsy Modality 

There are over 1 million breast biopsies performed in the United States each year that require breast biopsy marker placement. Currently manufactured biopsy markers use predominantly non-specific multidimensional shapes. This patent details a novel radiopaque alphanumeric breast biopsy marker specifically fashioned to permit the unique identification of patient breast biopsy location, date, and modality. This breast biopsy marker aims to minimize medical errors and inefficiency related to currently marketed breast biopsy markers. 

Computer Readable Medium (US #61/864,401) that Enables Automatic Localization of Breast Lesions Using Standard Clock-face and Nipple-distance Parameters. 

This patent details a software program that enables near-instantaneous reporting of clock-face and nipple-distance parameters by simply choosing (with cursor placement) the location of the breast lesion on two separate mammography projections (typically the craniocaudal and mediolateral oblique views). This method is more efficient, much more accurate and precise, and minimizes human interpretive error, thereby improving medical outcomes. 

Honors and Awards 
Excellence in Medical Education, Emory University Hospital  Excellence in Patient Care, Spartanburg Regional Community Hospital
Academic Excellence, University of South Florida College of Medicine
Superior Research Presentation, University of South Florida College of Medicine                                                                                    Valedictorian, United States Naval Academy Preparatory School  Summa cum laude, University of South Florida
Commanding Officers Personal Commendation, United States Navy
National Defense Service Medal, United States Navy

American College of Radiology
Radiological Society of North America                                             
Society of Breast Imaging                                                         
International Society of Clinical Densitometry                               
Federal Aviation Administration                                                      
Aircraft Owners and Pilots Association 


Contact Information

(912) 667-8654


435 Manor Blvd,Palm Harbor, Florida, 34683
United States